E. Bae

发表

Purification and Characterization of Ginsenoside Rb1-Metabolizing β-Glucosidase from Fusobacterium K-60, a Human Intestinal Anaerobic Bacterium

J. Sung, Dong-Hyun Kim, Sunyeob Park, 2001, Bioscience, biotechnology, and biochemistry.

Inhibitory effect of herbal medicines on rotavirus infectivity.

D. Kim, M. Han, E. A. Bae, 2000, Biological & pharmaceutical bulletin.

Metabolism of rhaponticin and chrysophanol 8-o-beta-D-glucopyranoside from the rhizome of rheum undulatum by human intestinal bacteria and their anti-allergic actions.

D. Kim, M. Han, E. Park, 2000, Biological & pharmaceutical bulletin.

Metabolism of puerarin and daidzin by human intestinal bacteria and their relation to in vitro cytotoxicity.

D. Kim, M. Han, E. A. Bae, 1998, Biological & pharmaceutical bulletin.

Metabolism of chiisanoside from Acanthopanax divaricatus var. albeofructus by human intestinal bacteria and its relation to some biological activities.

D. Kim, T. Nohara, S. Chang, 2001, Biological & pharmaceutical bulletin.

Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological activities

Dong-Hyun Kim, M. Han, S W Hong, 2000, Archives of pharmacal research.

Anti-Helicobacter pylori activity of quinolone alkaloids from Evodiae fructus.

J. Ahn, Bo Yeon Kim, W. Oh, 1999, Biological & pharmaceutical bulletin.

Inhibitory effect of ginsenoside Rg5 and its metabolite ginsenoside Rh3 in an oxazolone-induced mouse chronic dermatitis model

Dong Hyun Kim, E. Bae, Yong-wook Shin, 2006, Archives of pharmacal research.

Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria.

D. Kim, S. Park, E. Bae, 2000, Biological & pharmaceutical bulletin.

Metabolism of kalopanaxsaponin B and H by human intestinal bacteria and antidiabetic activity of their metabolites.

D. Kim, H. J. Park, K. Yu, 1998, Biological & pharmaceutical bulletin.